OSTEOPOROSIS: ARE WE MISSING A BETTER WAY?

Why Stronger Bones Require More Than a Prescription
By Dr. Greg Fors, Board-certified Chiropractic Neurologist
Clinic Director, Pain and Brain Healing Center
Chief Science Officer, Biospec Nutritionals
Key Takeaways
- Bones are living tissue that is constantly remodeling.
- A better DEXA score does not necessarily mean stronger, better-quality bone.
- Relative risk reduction can make a small absolute benefit sound enormous—ask for the absolute numbers.
- New-generation medications, including Prolia and Evenity, involve important considerations such as rebound effects and cardiovascular warnings.
- Osteoporosis rarely has one cause. Hormones, blood sugar, inflammation, nutrition, and muscle all matter.
- Osteopenia is a wake-up call to investigate now, and Carolyn’s experience shows what a comprehensive approach can make possible.
Imagine being 55 years old and learning that your bones resemble those of a 90-year-old woman. That’s exactly what happened to my wife, Carolyn, nearly 20 years ago.
Her bone density was frighteningly low. We knew what that could mean: broken hips, crushed vertebrae, chronic back pain, a hunched-over spine, and possibly losing her independence as she grew older.
And I shouldn’t have been entirely surprised. Carolyn’s grandmother had suffered from severe osteoporotic kyphosis, leaving her spine dramatically curved forward, or kyphotic, by age 65. Genetics plays an important role in osteoporosis, and Carolyn had a family history that should have raised concerns long before her first DEXA scan.
Naturally, the medical answer was medication. But Carolyn had another idea. She wanted to know why her bones were becoming so weak in the first place. And that question changed everything.
ARE WE TREATING OSTEOPOROSIS—OR JUST THE NUMBERS?
Here’s something I wish every woman understood: Your bones are alive!

They’re constantly rebuilding themselves. Special cells called osteoclasts remove old, worn-out bone, while other cells called osteoblasts build fresh, new bone. It’s a remarkable repair system that operates throughout your life.
So why do our bones become weaker as we age? And why does osteoporosis become such a serious problem for women after menopause? Those are the questions we should be asking.
Instead, our medical system often takes a different approach. We measure bone density with a DEXA scan, identify osteoporosis, and prescribe medication designed to slow bone breakdown.
But here’s my question: Why interfere with the body’s natural repair system before investigating why that system stopped working properly?
I’ve spent more than 40 years studying and practicing functional medicine, and this is one of my greatest frustrations with our drug-centered disease-care medical system. Too often, we’re treating the results of disease rather than the reasons it developed.
I’ve had women come into my office in tears because they’ve been told they need osteoporosis medication. They’re frightened by the possible side effects, but they’re equally frightened of breaking a hip or suffering a spinal fracture. They feel trapped between two terrible choices.
What breaks my heart is that many have never been offered a serious investigation into why their bones are deteriorating. Women deserve more than a prescription and a warning about what might happen if they refuse it.
DOES A BETTER DEXA SCORE MEAN STRONGER BONES?
Not necessarily. Think about an old house. You can paint the walls, replace the siding, and make everything look wonderful from the outside. But what if the wooden beams underneath are rotting?

Your bones are similar. A DEXA scan measures bone mineral density, but it doesn’t tell us everything about the strength and quality of the bone itself.
Some of the most commonly prescribed osteoporosis drugs, called bisphosphonates, work by slowing the vital cells that remove damaged and older bone. Bone density often increases, and the DEXA scan may look better, but what kind of bone is it?
Slowing the removal of old and damaged bone also changes the body’s natural remodeling process. This raises concerns about the accumulation of older bone and microscopic damage that the body would normally repair.
Use of bisphosphonate drugs has been linked to unusual fractures of the thigh bone, sometimes occurring with little or no trauma. Another serious complication is osteonecrosis of the jaw, in which damaged jawbone fails to heal normally. Ever wonder why your dentist asks whether you’re taking osteoporosis medications before performing certain dental procedures?
Because these medications can interfere with normal bone repair and, in some circumstances, contribute to serious problems with bone healing. That’s something every woman deserves to know before treatment begins.
Other potential problems include irritation of the esophagus, stomach discomfort, and significant muscle or bone pain. And remember, improving bone density is not the same as correcting all the factors that determine healthy bone strength.
BUT DON’T THESE DRUGS PREVENT FRACTURES?
That’s certainly what we’re told. And some osteoporosis medications have demonstrated reductions in fractures in clinical trials. But here’s where I believe the public deserves a much clearer explanation.
Drug companies frequently highlight something called relative risk reduction. It’s a wonderful way to make a modest gain sound enormous. Suppose a medication is advertised as reducing hip fractures by 50%.
Wow! That sounds like half the women taking the medication will be saved from a broken hip, doesn’t it? But let’s look at what those numbers might actually mean.
Imagine a study of 100 women who do not take the medication. Over the next three years, two suffer a hip fracture, while 98 do not. Now imagine another group of 100 similar women who take the medication. Only one suffers a hip fracture, while 99 do not.

The drug company can correctly announce a 50% relative risk reduction! And they do. It sounds like a really big deal, but is it?
Here’s what I want you to understand: Without the drug, 2 out of 100 women fractured a hip. With the drug, 1 out of 100 fractured a hip.
That’s a 50% relative reduction, but the absolute risk reduction is only 1 percentage point. How many drugs do you think they would sell if the advertising simply said, “This medication reduced the real risk of a hip fracture by one percentage point over three years”?
In this example, 100 women would need to take the medication for three years to prevent just one additional hip fracture. This is an illustration, not the result of every osteoporosis drug trial, but it demonstrates why the difference between relative and absolute risk matters so much.
With all the potential side effects of taking these drugs, shouldn’t we be talking about absolute risk reduction instead of relying on impressive advertising percentages?
These medications carry meaningful risks. Women deserve to know how much protection they are actually getting in exchange for accepting those risks.
And shouldn’t we ask who funded the research, who stands to profit, and whether the studies followed patients long enough to identify problems that develop after years of treatment? Financial relationships, selective reporting, and the way studies present their findings absolutely deserve scrutiny.
When billions of dollars are involved, we need to follow the money as carefully as we follow the science.
WHAT ABOUT THE NEW GENERATION OF OSTEOPOROSIS DRUGS?
You might assume that newer medications have solved the problems associated with older osteoporosis drugs. Unfortunately, the picture is much more complicated.
Consider Prolia, an injection given every six months. It again strongly suppresses the cells responsible for keeping bones healthy and strong: osteoclasts that break down weak, damaged, and old bone.
But here’s the catch: when Prolia is stopped or significantly delayed, bone breakdown can rebound dramatically. Bone density can fall rapidly, and some women experience multiple spinal compression fractures!
Think about that. A woman starts a medication to protect herself from fractures, only to discover that stopping it without another treatment can create a serious problem. This is why women taking Prolia generally need a carefully planned transition to another osteoporosis medication if treatment ends.
Then there’s Evenity, a newer medication designed to increase bone formation while also reducing bone breakdown.
It sounds promising. But Evenity carries a boxed warning about heart attack, stroke, and cardiovascular death. It should not be started in someone who has experienced a heart attack or stroke.
And here’s another complication: Evenity can be given for only 12 months. Why? Because its bone-building effect diminishes substantially over that year. And when you stop it, there is a rebound in bone turnover, leading to loss of the bone-density gains.
After those 12 months, treatment with a medication that suppresses bone breakdown is generally recommended to preserve any possible gains in bone density. Without follow-up treatment, those gains can diminish. That may mean moving on to a bisphosphonate such as Fosamax or another antiresorptive drug.
In one major Evenity trial, the absolute reduction in new vertebral fractures over 12 months was approximately 1.3 percentage points. That means roughly 77 women would need to receive treatment to prevent just one additional new vertebral fracture during that period in that group.

That’s a very different way of presenting the results than simply announcing a large relative reduction.
Other bone-building drugs, including Forteo and Tymlos, also involve limited treatment courses and generally require follow-up treatment to preserve the improvements.
Forteo and Tymlos can cause dizziness, nausea, and changes in calcium levels. Evenity raises cardiovascular concerns. Prolia requires particular care when treatment is stopped. Bisphosphonates have their own long-term complications.
Doesn’t every woman deserve to understand the entire treatment journey before she takes the first dose?
What bothers me is the way these medications are often presented to physicians. Doctors know that a hip fracture or spinal compression fracture can be devastating. The argument becomes: If a medication prevents even one fracture among 100 women treated, then the risks are worth taking, even with all the side effects.
But wait a minute. Is that really the only choice we should be offering women?
Consider the Evenity example. Approximately 77 women receive treatment for a year to prevent one additional new vertebral fracture. Meanwhile, every woman receiving the medication is exposed to its potential adverse effects, including cardiovascular issues, and those who complete treatment are generally advised to begin another medication to preserve any possible gains.
That means all 77 women were exposed to the possibility of side effects. Doesn’t this mean every woman deserves to understand the possible consequences, as well as the actual benefit?
Now consider another approach—one that begins by investigating the reasons a woman’s bones are deteriorating.
Look at Carolyn. She had severe osteoporosis and a family history of spinal deformity. Rather than relying on medication, I developed a comprehensive, personalized program addressing her nutrition, metabolic health, exercise, and the nutrients involved in bone formation.
And here’s something I find remarkable about that approach: Improving your nutrition, correcting deficiencies, building muscle, and improving metabolic health can benefit far more than your bones.
These changes can support cardiovascular health, blood sugar control, physical strength, balance, and overall well-being. In other words, instead of treating one problem while potentially creating others, we’re working to improve the health of the entire person. This means we should recognize the broad benefits of improving the biological conditions that support health.
After more than 40 years of practicing functional and lifestyle medicine, I still find it astonishing how readily our healthcare system reaches for another prescription while giving so little attention to the hard work of changing nutrition, exercise, and lifestyle.
Perhaps part of the problem is that taking a pill is easier than changing the way we live. But the easiest choice isn’t necessarily the best choice for our long-term health.
What I am saying is that the consequences of these drugs can be significant, and the decision deserves much more than a quick discussion of an improved DEXA score.
Why aren’t we putting the same energy into helping women restore their health that we put into convincing them to take another medication?
WHY ISN’T THE FIRST QUESTION: WHAT CAUSED THE BONE LOSS?
This is where I believe our medical system has lost its way. When a woman develops osteoporosis, why don’t we begin by asking what is interfering with her body’s ability to maintain healthy bone?
Is she getting enough protein? Is she absorbing calcium properly? Does she have adequate vitamin D? Has menopause dramatically changed her hormonal balance? Is she insulin resistant? Does she have chronic inflammation? Is she losing muscle mass?
And what about the nutrients and biological signals that help osteoblasts build new bone? These questions matter because osteoporosis is not simply a shortage of medication. It is a complex biological problem involving the balance between bone breakdown and bone formation. That was the starting point for Carolyn’s recovery.
CAROLYN DECIDED TO TAKE A DIFFERENT ROAD
When Carolyn learned how osteoporosis medications worked and researched their potential complications, she wasn’t comfortable with the idea of simply taking a drug and hoping for the best.
She wanted to understand why her bones had deteriorated so dramatically at such a young age. So I began investigating.
Had she received enough of the nutrients necessary to build and maintain healthy bones, particularly through three pregnancies? What role had menopause played? Could inflammation, metabolic health, exercise, and other factors have contributed to her severe bone loss?
Instead of focusing on one number, I looked at the whole person, as I do with all my patients. I developed a comprehensive program centered on nutrition, targeted nutritional supplements, appropriate exercise, and improving the biological conditions that support healthy bone formation.
It wasn’t a quick fix. It required commitment, consistency, and a willingness to take responsibility for her health—which may be one reason so many patients turn to a simple pill instead. But Carolyn was determined.
Today, at age 74, she has not experienced the spinal compression fractures, progressive stooped posture, or devastating disability we feared nearly 20 years ago. She now maintains a very active lifestyle, hiking, sailing, and playing with our grandchildren.
Her bone-density measurements have improved, and recent blood tests examining bone breakdown and formation have also been encouraging.
One of those tests is called CTX, which measures a substance released when bone is broken down. Carolyn’s CTX has been in the low-normal range.
Another test, P1NP, reflects the activity of cells building new bone. Carolyn’s P1NP has been toward the upper end of the normal range.
These results are encouraging because they provide information about the balance of bone remodeling, especially alongside the improvement in her DEXA scans through the years. These bone markers help us understand how her bones are functioning.

Carolyn’s experience shows what can be possible when someone with severe osteoporosis commits to a comprehensive program addressing the many factors involved in bone health.
For nearly 20 years, she has worked to support her body’s ability to maintain healthy bones rather than relying on medication to suppress bone breakdown. And that is a very different way of thinking about osteoporosis.
YOUR BONES DON’T GET WEAK FOR JUST ONE REASON
Here’s what I’ve learned from decades of clinical practice: osteoporosis rarely develops because of one isolated problem. Your bones are influenced by your hormones, blood sugar, inflammation, nutrition, muscle strength, and physical activity.
After menopause, declining estrogen can accelerate bone loss. Insulin resistance and diabetes can affect bone quality. Chronic inflammation can increase bone breakdown. Poor nutrition can deprive your bones of the materials they need to rebuild.
And if you’re not using your muscles, your bones receive less of the physical stimulation that helps keep them strong.

Each of these factors can add another log to the fire.
That’s why simply taking calcium—or even taking a prescription medication—doesn’t address the entire problem. We need to look at what’s happening throughout the body.
WHAT CAN YOU DO TO BUILD HEALTHIER BONES?
First, stop thinking of osteoporosis as something that simply happens to women as they get older. Aging matters, but it isn’t the whole story.
Your bones need adequate protein, calcium, vitamin D, and other nutrients involved in normal bone maintenance. They need the physical stimulation of resistance training and appropriate weight-bearing exercise. Your muscles need to remain strong, and your balance needs attention so you’re less likely to fall.
Just as importantly, we need to identify and address the underlying problems that may be accelerating bone loss, including hormonal changes, poor metabolic health, nutritional deficiencies, and chronic inflammation.
Targeted nutraceuticals can be considered as part of a personalized bone-health program, based on an individual’s needs and the evidence supporting particular ingredients. I will examine all these things in part three of this article series.
In my practice, I use the blood tests CTX and P1NP to help evaluate bone breakdown and bone formation. These markers can be useful for assessing progress, whether a woman is following a nutritional and lifestyle program or receiving medication.

Along with DEXA scans and other clinical information, they help us better understand how a woman’s bones are responding over time. The goal is not simply to make a number on a scan look better.
The goal is to help your body maintain stronger, healthier bones for the rest of your life.
OSTEOPENIA IS YOUR WAKE-UP CALL!
If you’ve been told you have osteopenia, don’t simply shrug your shoulders and wait until it becomes osteoporosis. Osteopenia means your bone density is already below the young-adult reference range. It doesn’t mean you’re destined for a fracture, but it gives you an excellent reason to investigate your bone health now.

And if you’ve already been diagnosed with osteoporosis, don’t give up hope. Carolyn’s story is a powerful reminder of what can be possible when we take a comprehensive approach and make bone health a lifelong priority.
I believe the best time to begin protecting your bones is long before your first fracture. Why wait until something breaks before you start fixing what’s wrong?
THERE IS HOPE—AND THE TIME TO ACT IS NOW!
At the Pain and Brain Healing Center, we approach osteoporosis and osteopenia differently.
Rather than focusing exclusively on bone-density scores, we investigate the nutritional, metabolic, hormonal, inflammatory, and lifestyle factors that may be contributing to bone loss.
Our goal is to help you understand what’s happening inside your body and develop a personalized program to support healthier bones, stronger muscles, and greater independence as you age.
Whether you have just been diagnosed with osteopenia or have struggled with osteoporosis for years, I encourage you to take control of your bone health.
Don’t wait for a broken hip or a crushed vertebra to become your wake-up call.
Call the Pain and Brain Healing Center at 763-862-7100 to learn more about our comprehensive approach.
Your bones are living tissue. Your future is not written in stone. There is hope—and the time to act is now.
Dr. Greg Fors
Clinic Director, Pain and Brain Healing Center
Chief Science Officer, Biospec Nutritionals
Related Reading
- America’s Metabolic Epidemic: Insulin Resistance Is Destroying Our Health One Meal at a Time
- Why Can’t You Lose the Weight? Because Your Brain May Think You’re Starving!
- Chronic Symptoms, and Nobody Can Tell You Why?
Ready to address the root cause?
Call (763) 862-7100 or visit https://painandbrainhealingcenter.com/free-consultation-intake/ to explore a root-cause, functional medicine evaluation.
This article is for educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. Do not change medications or begin a new treatment program without speaking with a qualified healthcare professional.